FMCG - Personal Care Stocks in India
FMCG - Personal Care: Hindustan Unilever Ltd owns the largest revenue base; Zydus Wellness Ltd has the fastest current growth.
The 12 FMCG - Personal Care companies listed in India are Hindustan Unilever Ltd (₹4.5 L Cr, the largest), Marico Ltd, Godrej Consumer Products Ltd and 9 more. 3 of 12 covered companies beat NIFTY 500 on relative strength. Readings are as of 17 Sep 2026.
Top 10 FMCG - Personal Care Stocks in India (Sep 2026) — ranked by 4-Factor score
- 1Bajaj Consumer Care Ltd₹6.8K Cr73.5/100Favorable setup · strongest on profit growth and relative strength versus sector
- 2Gillette India Ltd₹23.8K Cr67.2/100Favorable setup · strongest on ROCE and ROCE improvement
- 3Marico Ltd₹1.0 L Cr64.4/100Mixed-positive evidence · strongest on ROCE and relative strength versus sector
- 4Hindustan Unilever Ltd₹4.5 L Cr61.6/100Mixed-positive evidence · strongest on PEG and profit growth
- 5Dabur India Ltd₹66.7K Cr52.7/100Mixed-positive evidence · strongest on own-history P/E and relative strength versus sector
- 6Procter & Gamble Hygiene and Health Care Ltd₹24.4K Cr49.5/100Mixed-negative evidence · strongest on ROCE and ROCE improvement
- 7Colgate-Palmolive (India) Ltd₹48.9K Cr47.5/100Mixed-negative evidence · strongest on ROCE and operating margin
- 8Zydus Wellness Ltd₹17.6K Cr42.3/100Mixed-negative evidence · strongest on relative strength versus sector and revenue growth
- 9Emami Ltd₹15.9K Cr37.7/100Mixed-negative evidence · strongest on 13-week relative-strength change and sector-relative P/E
- 10Jyothy Labs Ltd₹7.2K Cr36.3/100Mixed-negative evidence · strongest on 13-week relative-strength change and ROCE
Ranked by the 4-Factor Sector Score (growth & earnings 35, capital efficiency 25, valuation 20, relative strength 20). Prices as of 11 Sep 2026. Not investment advice.
Nifty FMCG - Personal Care Index — Constituents & Performance
All 12 listed Indian FMCG - Personal Care companies are named here, largest first — the same constituent set people search for as the Nifty FMCG - Personal Care index. Every figure is equal-weighted across those companies and carries its own as-of date. One large constituent cannot set the reading.
- Hindustan Unilever Ltd₹4.5 L Cr
- Marico Ltd₹1.0 L Cr
- Godrej Consumer Products Ltd₹88.5K Cr
- Dabur India Ltd₹66.7K Cr
- Colgate-Palmolive (India) Ltd₹48.9K Cr
- Procter & Gamble Hygiene and Health Care Ltd₹24.4K Cr
- Gillette India Ltd₹23.8K Cr
- Zydus Wellness Ltd₹17.6K Cr
- Emami Ltd₹15.9K Cr
- Jyothy Labs Ltd₹7.2K Cr
- Bajaj Consumer Care Ltd₹6.8K Cr
- Polo Queen Industrial and Fintech Ltd₹638 Cr
How has FMCG - Personal Care moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 23% behind NIFTY 500. Earnings across its companies grew 4% on average over the last four reported quarters — close to flat.
RS — · 3/12 >200d (+0) · 1/12 lead (+1) · EPS 6/12↑
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 12 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Is FMCG - Personal Care outperforming NIFTY 500?
FMCG - Personal Care has underperformed NIFTY 500 by 17.5% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 6.6%. 3 of 12 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Bajaj Consumer Care Ltd is the strongest against the sector itself at +41.4%.
Sector metric: — as of latest available · unclassified · direction unavailable.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
FMCG - Personal Care has underperformed NIFTY 500 by 17.5% over 52 weeks and 6.6% over 13 weeks. 3 of 12 covered companies beat NIFTY on Mansfield relative strength, while 4 of 12 beat the sector itself. Hindustan Unilever Ltd leads with revenue of ₹66,052 crore, based on 12 of 12 comparable companies through Jun 2026.
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Bajaj Consumer Care LtdBAJAJCON | 73.5/100Favorable setup100% evidence | ASLEEP | 32.3/35 Revenue 25.1% · PAT 77% · OPM change 9 pp 100% evidence | 16.9/25 ROCE 30% · OPM 24% 100% evidence | 10.3/20 P/E 30.5× · PEG 1.64 100% evidence | 14.0/20 RS sector 41.4% · RS bench 30.2% · 1Y 131.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 32.3 + 16.9 + 10.3 + 14 = 73.5 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Gillette India LtdGILLETTE | 67.2/100Favorable setup94% evidence | BASING | 23.9/35 Revenue 8% · PAT 18.4% · OPM change -1 pp 100% evidence | 18.6/25 ROCE 90.7% · OPM 29% 100% evidence | 14.5/20 P/E 35.6× · PEG 1.7 100% evidence | 10.2/20 RS sector -1.4% · RS bench -9.6% · 1Y -30.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 23.9 + 18.6 + 14.5 + 10.2 = 67.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Marico LtdMARICO | 64.4/100Mixed-positive evidence82% evidence | ASLEEP | 25.8/35 Revenue 25.1% · PAT 15% · OPM change 1 pp 95% evidence | 17.9/25 ROCE 47% · OPM 21% 76% evidence | 5.8/20 P/E 55.2× · PEG — 50% evidence | 14.9/20 RS sector 13.6% · RS bench 4.3% · 1Y 9.6%5 of 12 weeks ahead 100% evidence |
| Exact sum: 25.8 + 17.9 + 5.8 + 14.9 = 64.4 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Hindustan Unilever LtdHINDUNILVR | 61.6/100Mixed-positive evidence100% evidence | BASING | 24.7/35 Revenue 5.8% · PAT 38.3% · OPM change 0 pp 100% evidence | 14.0/25 ROCE 28.4% · OPM 23% 100% evidence | 16.9/20 P/E 41.1× · PEG 0.72 100% evidence | 6.0/20 RS sector -5% · RS bench -13.1% · 1Y -23.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 24.7 + 14 + 16.9 + 6 = 61.6 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -5% and the one-year return is -23.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 5Dabur India LtdDABUR | 52.7/100Mixed-positive evidence94% evidence | BASING | 18.6/35 Revenue 7.4% · PAT 10.9% · OPM change 0 pp 100% evidence | 14.6/25 ROCE 20.3% · OPM 20% 100% evidence | 9.1/20 P/E 33.6× · PEG 5.04 100% evidence | 10.4/20 RS sector 0.3% · RS bench -18.4% · 1Y -31.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.6 + 14.6 + 9.1 + 10.4 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Procter & Gamble Hygiene and Health Care LtdPGHH | 49.5/100Mixed-negative evidence94% evidence | BASING | 13.4/35 Revenue -1.6% · PAT -4.7% · OPM change -9 pp 100% evidence | 18.3/25 ROCE 157% · OPM 19% 100% evidence | 14.0/20 P/E 30.9× · PEG 1.77 100% evidence | 3.8/20 RS sector -15.8% · RS bench -30% · 1Y -44.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.4 + 18.3 + 14 + 3.8 = 49.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 7Colgate-Palmolive (India) LtdCOLPAL | 47.5/100Mixed-negative evidence94% evidence | ASLEEP | 11.0/35 Revenue 3.8% · PAT -3.3% · OPM change -2 pp 100% evidence | 21.5/25 ROCE 108% · OPM 30% 100% evidence | 5.6/20 P/E 35.7× · PEG 6.07 100% evidence | 9.4/20 RS sector -1.5% · RS bench -12.9% · 1Y -25.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 11 + 21.5 + 5.6 + 9.4 = 47.5 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 8Zydus Wellness LtdZYDUSWELL | 42.3/100Mixed-negative evidence100% evidence | TURNING | 11.2/35 Revenue 66.3% · PAT -42.5% · OPM change -1 pp 100% evidence | 6.5/25 ROCE 4.9% · OPM 17% 100% evidence | 6.1/20 P/E 79.3× · PEG 1.75 100% evidence | 18.5/20 RS sector 27.6% · RS bench 17% · 1Y 13.7%6 of 12 weeks ahead 100% evidence |
| Exact sum: 11.2 + 6.5 + 6.1 + 18.5 = 42.3 · Decision use: Price leads the evidence: RS versus the benchmark is 17%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 9Emami LtdEMAMILTD | 37.7/100Mixed-negative evidence100% evidence | BASING | 7.7/35 Revenue 2.8% · PAT -8.2% · OPM change -1 pp 100% evidence | 14.3/25 ROCE 28.1% · OPM 22% 100% evidence | 9.3/20 P/E 21× · PEG 2.99 100% evidence | 6.4/20 RS sector -12.5% · RS bench -20.1% · 1Y -39.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 7.7 + 14.3 + 9.3 + 6.4 = 37.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Jyothy Labs LtdJYOTHYLAB | 36.3/100Mixed-negative evidence100% evidence | BASING | 5.1/35 Revenue 3.9% · PAT -22.1% · OPM change -9 pp 100% evidence | 13.2/25 ROCE 28.7% · OPM 8% 100% evidence | 8.7/20 P/E 25.2× · PEG 5.24 100% evidence | 9.3/20 RS sector -12.2% · RS bench -19.9% · 1Y -41.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 5.1 + 13.2 + 8.7 + 9.3 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Godrej Consumer Products LtdGODREJCP | 31.7/100Adverse evidence100% evidence | ASLEEP | 15.6/35 Revenue 9.2% · PAT 3.3% · OPM change 0 pp 100% evidence | 9.6/25 ROCE 18.8% · OPM 19% 100% evidence | 3.4/20 P/E 42.6× · PEG 7.49 100% evidence | 3.1/20 RS sector -12.4% · RS bench -19.9% · 1Y -29.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.6 + 9.6 + 3.4 + 3.1 = 31.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Polo Queen Industrial and Fintech LtdPQIF | 34.3/100Thin evidence · provisional50% evidence | 15.1/35 Revenue -25.8% · PAT -16.1% · OPM change 0.3 pp 53% evidence | 7.7/25 ROCE 2.5% · OPM 7.6% 57% evidence | 8.5/20 P/E 223× · PEG — 15% evidence | 3.0/20 RS sector -54.8% · RS bench -58.4% · 1Y -61.4%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.1 + 7.7 + 8.5 + 3 = 34.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Market action
Bajaj Consumer Care Ltd has the strongest one-year price move in FMCG - Personal Care at +131.1%. It also leads on Mansfield relative strength against NIFTY at +30.2%. 3 of 12 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-09-11.
Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against FMCG - Personal Care itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
FMCG - Personal Care — the story behind the numbers
This is the written read behind the FMCG - Personal Care figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 18 Apr 2026, so the words are older than the numbers. 5 themes are live here, 1 of them rated high severity.
The FMCG Personal Care sector is firmly in an expansionary phase. Despite isolated bottom-line pressures—such as ZYDUSWELL's ₹399 million net loss due to acquisition financing costs—the underlying gross margin expansion, aggressive TAM expansion into digital-first brands, and unanimous reports of an improving demand environment make the sector highly attractive.
The FMCG Personal Care sector is demonstrating a robust and accelerating recovery, characterized by aggressive top-line expansion and significant margin accretion. BAJAJCON posted a stellar 32.3% YoY revenue growth to INR 326.5 Cr, driven by a sharp recovery in rural markets.
How old this read is: STALE — this read comes from our FMCG - Personal Care sector brief dated 18 Apr 2026, about 5 months ago. The page says so rather than dressing it up, and a fresh sector dive replaces it the day it runs.
What is live in this sector right now
| Live theme | Severity | Evidence on file |
|---|---|---|
| Divergent raw material trends causing pricing and margin volatility across the sector.Named for BAJAJCON, MARICO, ZYDUSWELL | high | “With correction having set in and copra prices down by around 25% to 30% from peak levels, the brand will be passing on the benefit.” Inventory positioning (BAJAJCON) and passing benefits to consumers to drive volume (MARICO). |
| Weakness in international markets like GCC, Africa, and RoW.Named for BAJAJCON | low | “RoW and GCC & Africa remained weak and declined in the quarter and for the year.” New leadership in place to drive sequential improvement and focus on Nepal/Bangladesh breakeven. |
| Exposure to Euro and GBP fluctuations due to international acquisitions.Named for ZYDUSWELL | low | “And euro-rupee depreciation or GBP-rupee depreciation is in the range of 3%, 4% on an annualized basis.” Refinancing GBP loan into Euro to align with cash flow generation. |
| GST rate rationalization impacting pricing dynamics.Named for MARICO | low | “improved affordability following the recent GST rate rationalization, which has been transformative” Viewed as a constructive backdrop for demand improvement. |
| One-time impacts arising from the implementation of the new labour code.Named for ZYDUSWELL | low | “Exceptional items primarily represent onetime impacts arising from the implementation of new labour code” Treated as a one-time exceptional impact. |
Sources: our FMCG - Personal Care sector brief, 18 Apr 2026 · company earnings-call transcripts.
Revenue Scale & Growth Durability
Hindustan Unilever Ltd has the highest Revenue among the 12 FMCG - Personal Care companies compared here, at ₹66,052 crore. Godrej Consumer Products Ltd is next at ₹15,948 crore. Zydus Wellness Ltd has the highest Revenue growth at 66.3%, so level and change sit with different companies. 12 of 12 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Hindustan Unilever Ltd is the scale leader at ₹66,052 crore, 314.2% ahead of Godrej Consumer Products Ltd. Zydus Wellness Ltd's growth is 66.3% from a ₹4,537 crore base, with 20 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: Hindustan Unilever Ltd is the scale benchmark; Zydus Wellness Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Hindustan Unilever Ltd's growth falls below Zydus Wellness Ltd's for two consecutive comparable reports while operating margin also compresses.
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Hindustan Unilever Ltd HINDUNILVR | ₹17.3K Cr | 10% | Jun 2026 |
| Godrej Consumer Products Ltd GODREJCP | ₹4.2K Cr | 15% | Jun 2026 |
| Marico Ltd MARICO | ₹4.0K Cr | 23% | Jun 2026 |
| Dabur India Ltd DABUR | ₹3.8K Cr | 11% | Jun 2026 |
| Colgate-Palmolive (India) Ltd COLPAL | ₹1.6K Cr | 12% | Jun 2026 |
| Zydus Wellness Ltd ZYDUSWELL | ₹1.4K Cr | 67% | Jun 2026 |
| Emami Ltd EMAMILTD | ₹1.0K Cr | 15% | Jun 2026 |
| Procter & Gamble Hygiene and Health Care Ltd PGHH | ₹891 Cr | -4.9% | Jun 2026 |
| Gillette India Ltd GILLETTE | ₹783 Cr | 11% | Jun 2026 |
| Jyothy Labs Ltd JYOTHYLAB | ₹773 Cr | 2.9% | Jun 2026 |
| Bajaj Consumer Care Ltd BAJAJCON | ₹342 Cr | 25% | Jun 2026 |
| Polo Queen Industrial and Fintech Ltd PQIF | ₹17 Cr | -3.0% | Dec 2025 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Revenue growth · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Operating Economics & Margin Trend
Colgate-Palmolive (India) Ltd has the highest OPM among the 12 FMCG - Personal Care companies compared here, at 30%. Gillette India Ltd is next at 29%. Bajaj Consumer Care Ltd has the highest Margin change at +9 percentage points, so level and change sit with different companies. 12 of 12 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Colgate-Palmolive (India) Ltd leads opm at 30%; Bajaj Consumer Care Ltd leads margin change at +9 percentage points.
Investor read: Colgate-Palmolive (India) Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Colgate-Palmolive (India) Ltd COLPAL | 30% | −2.0 pp | Jun 2026 |
| Gillette India Ltd GILLETTE | 29% | −1.0 pp | Jun 2026 |
| Bajaj Consumer Care Ltd BAJAJCON | 24% | +9.0 pp | Jun 2026 |
| Hindustan Unilever Ltd HINDUNILVR | 23% | 0.0 pp | Jun 2026 |
| Emami Ltd EMAMILTD | 22% | −1.0 pp | Jun 2026 |
| Marico Ltd MARICO | 21% | +1.0 pp | Jun 2026 |
| Dabur India Ltd DABUR | 20% | 0.0 pp | Jun 2026 |
| Godrej Consumer Products Ltd GODREJCP | 19% | 0.0 pp | Jun 2026 |
| Procter & Gamble Hygiene and Health Care Ltd PGHH | 19% | −9.0 pp | Jun 2026 |
| Zydus Wellness Ltd ZYDUSWELL | 17% | −1.0 pp | Jun 2026 |
| Jyothy Labs Ltd JYOTHYLAB | 8.0% | −9.0 pp | Jun 2026 |
| Polo Queen Industrial and Fintech Ltd PQIF | 7.6% | +0.3 pp | Dec 2025 |
Full 20-quarter history · every available company
OPM · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Margin change · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Profit Scale & Acceleration
Hindustan Unilever Ltd has the highest Net profit among the 12 FMCG - Personal Care companies compared here, at ₹14,971 crore. Marico Ltd is next at ₹1,952 crore. Bajaj Consumer Care Ltd has the highest Profit growth at 77%, so level and change sit with different companies. 12 of 12 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Hindustan Unilever Ltd leads with ₹14,971 crore of TTM profit, 667% above Marico Ltd. Bajaj Consumer Care Ltd shows 77% growth from a ₹223 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Hindustan Unilever Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Hindustan Unilever Ltd HINDUNILVR | ₹2.7K Cr | -3.2% | Jun 2026 |
| Marico Ltd MARICO | ₹652 Cr | 27% | Jun 2026 |
| Dabur India Ltd DABUR | ₹586 Cr | 15% | Jun 2026 |
| Godrej Consumer Products Ltd GODREJCP | ₹505 Cr | 12% | Jun 2026 |
| Colgate-Palmolive (India) Ltd COLPAL | ₹343 Cr | 6.9% | Jun 2026 |
| Gillette India Ltd GILLETTE | ₹159 Cr | 8.9% | Jun 2026 |
| Emami Ltd EMAMILTD | ₹139 Cr | -15% | Jun 2026 |
| Procter & Gamble Hygiene and Health Care Ltd PGHH | ₹126 Cr | -34% | Jun 2026 |
| Zydus Wellness Ltd ZYDUSWELL | ₹119 Cr | -7.0% | Jun 2026 |
| Bajaj Consumer Care Ltd BAJAJCON | ₹71 Cr | 87% | Jun 2026 |
| Jyothy Labs Ltd JYOTHYLAB | ₹48 Cr | -51% | Jun 2026 |
| Polo Queen Industrial and Fintech Ltd PQIF | ₹1 Cr | 15% | Dec 2025 |
Full 20-quarter history · every available company
Net profit · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Profit growth · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Return On Capital Employed
Procter & Gamble Hygiene and Health Care Ltd has the highest ROCE among the 12 FMCG - Personal Care companies compared here, at 157%. Colgate-Palmolive (India) Ltd is next at 108%. Gillette India Ltd has the highest ROCE change at +21.2 percentage points, so level and change sit with different companies.
What the numbers say: Procter & Gamble Hygiene and Health Care Ltd leads ROCE at 157%, 49 percentage points above Colgate-Palmolive (India) Ltd. Gillette India Ltd has the strongest latest improvement at +21.2 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: Procter & Gamble Hygiene and Health Care Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
Withheld from this chart: Marico Ltd (MARICO) — its two data sources disagree by up to 4% on reported income across 14 comparable periods, so its derived ratios are withheld. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Procter & Gamble Hygiene and Health Care Ltd PGHH | 131% | +18.5 pp | Jun 2026 |
| Colgate-Palmolive (India) Ltd COLPAL | 104% | +0.3 pp | Jun 2026 |
| Gillette India Ltd GILLETTE | 82% | +21.2 pp | Jun 2026 |
| Bajaj Consumer Care Ltd BAJAJCON | 36% | +16.3 pp | Jun 2026 |
| Hindustan Unilever Ltd HINDUNILVR | 30% | +7.0 pp | Jun 2026 |
| Emami Ltd EMAMILTD | 26% | −4.8 pp | Jun 2026 |
| Jyothy Labs Ltd JYOTHYLAB | 24% | −6.5 pp | Jun 2026 |
| Godrej Consumer Products Ltd GODREJCP | 23% | −0.7 pp | Jun 2026 |
| Dabur India Ltd DABUR | 17% | +0.6 pp | Jun 2026 |
| Zydus Wellness Ltd ZYDUSWELL | 3.7% | −2.5 pp | Jun 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
ROCE change · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
Valuation Against Growth & Quality
Hindustan Unilever Ltd has the lowest PEG among the 12 FMCG - Personal Care companies compared here, at 0.72×. Bajaj Consumer Care Ltd is next at 1.64×. Emami Ltd has the lowest P/E at 21×, so level and change sit with different companies. 10 of 12 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Hindustan Unilever Ltd has the lowest comparable PEG at 0.72×, 56.1% below Bajaj Consumer Care Ltd. Only 10 of 12 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
All-company data · latest reported quarter
| Company | PEG | P/E | Reported |
|---|---|---|---|
| Godrej Consumer Products Ltd GODREJCP | 7.5 | 52.2 | Jun 2026 |
| Colgate-Palmolive (India) Ltd COLPAL | 6.1 | 40.3 | Jun 2026 |
| Jyothy Labs Ltd JYOTHYLAB | 5.2 | 22.8 | Jun 2026 |
| Dabur India Ltd DABUR | 5.0 | 39.4 | Jun 2026 |
| Emami Ltd EMAMILTD | 3.0 | 22.1 | Jun 2026 |
| Procter & Gamble Hygiene and Health Care Ltd PGHH | 1.8 | 34.2 | Jun 2026 |
| Zydus Wellness Ltd ZYDUSWELL | 1.8 | 71.6 | Jun 2026 |
| Gillette India Ltd GILLETTE | 1.7 | 38.4 | Jun 2026 |
| Bajaj Consumer Care Ltd BAJAJCON | 1.6 | 40.0 | Jun 2026 |
| Hindustan Unilever Ltd HINDUNILVR | 0.7 | 33.5 | Jun 2026 |
| Marico Ltd MARICO | — | 60.8 | Jun 2026 |
| Polo Queen Industrial and Fintech Ltd PQIF | — | 409.4 | Dec 2025 |
Full 20-quarter history · every available company
PEG · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
P/E · reported quarter history
Bajaj Consumer Care Ltd · BAJAJCON
Colgate-Palmolive (India) Ltd · COLPAL
Dabur India Ltd · DABUR
Emami Ltd · EMAMILTD
Gillette India Ltd · GILLETTE
Godrej Consumer Products Ltd · GODREJCP
Hindustan Unilever Ltd · HINDUNILVR
Jyothy Labs Ltd · JYOTHYLAB
Marico Ltd · MARICO
Polo Queen Industrial and Fintech Ltd · PQIF
Procter & Gamble Hygiene and Health Care Ltd · PGHH
Zydus Wellness Ltd · ZYDUSWELL
What can make this comparison misleading?
This FMCG - Personal Care comparison names 6 specific ways its own evidence can mislead, all listed below. 1 of the 12 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 1 has second-feed figures withheld because the two sources disagree. A high growth rate can still be a low-base artefact.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 1 company has an older fundamental reporting date than the sector’s freshest reporters; its rank carries a stale marker.
- 1 company is missing from the second-feed metrics by decision, not by absence: the two sources disagree, so nothing from the second is drawn. Read those rows as narrower evidence, never as a weaker business.
How was this comparison built?
This comparison is built from the reported filings of 12 FMCG - Personal Care companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-09-11. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
FMCG - Personal Care company comparison FAQs
These 24 answers restate the FMCG - Personal Care comparison above in question form. Every one is computed from the same 12 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-09-11. Nothing here is estimated, and none of it is a recommendation.
Is the FMCG - Personal Care sector outperforming NIFTY 500?
FMCG - Personal Care has underperformed NIFTY 500 by 17.5% over 52 weeks and 6.6% over 13 weeks. 3 of 12 covered companies beat NIFTY on Mansfield relative strength, while 4 of 12 beat the sector itself.
Which FMCG - Personal Care company is largest by revenue?
Hindustan Unilever Ltd leads with revenue of ₹66,052 crore, based on 12 of 12 comparable companies through Jun 2026.
Which FMCG - Personal Care company is growing fastest?
Zydus Wellness Ltd has the fastest current revenue growth at 66.3%, across 12 of 12 comparable companies.
Which FMCG - Personal Care company has the strongest 4-Factor Sector Score?
Bajaj Consumer Care Ltd ranks first at 73.5/100 with 100% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which FMCG - Personal Care company has the lowest comparable PEG?
Hindustan Unilever Ltd has the lowest comparable PEG at 0.72, among 10 of 12 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this FMCG - Personal Care comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Is there a Nifty FMCG - Personal Care index?
NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers FMCG - Personal Care, this page builds its own equal-weight basket of 12 listed FMCG - Personal Care companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.
Which are the best FMCG - Personal Care stocks in India?
Ranked by this page's four-factor score, Bajaj Consumer Care Ltd places first among 12 listed FMCG - Personal Care companies, followed by Gillette India Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many FMCG - Personal Care stocks are listed in India?
This comparison covers 12 listed FMCG - Personal Care companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which FMCG - Personal Care company is the biggest?
Hindustan Unilever Ltd is the largest, with trailing-twelve-month revenue of ₹66,052 crore, ahead of Godrej Consumer Products Ltd at ₹15,948 crore. That covers 12 of 12 companies with comparable reporting through Jun 2026.
Which FMCG - Personal Care company has the best profit margins?
Colgate-Palmolive (India) Ltd has the highest operating margin at 30%, from 12 of 12 comparable companies. Bajaj Consumer Care Ltd shows the biggest recent improvement, at +9 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which FMCG - Personal Care company makes the most profit?
Hindustan Unilever Ltd earns the most, at ₹14,971 crore of trailing-twelve-month net profit, from 12 of 12 comparable companies. Bajaj Consumer Care Ltd has the fastest profit growth at 77%, though growth off a small or recovering profit base overstates how much has actually changed.
Which FMCG - Personal Care company earns the highest return on capital?
Procter & Gamble Hygiene and Health Care Ltd leads on return on capital employed at 157%, across 12 of 12 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which FMCG - Personal Care stock is the cheapest?
On PEG — where a LOWER number is cheaper — Hindustan Unilever Ltd screens cheapest at 0.72×. Only 10 of 12 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the FMCG - Personal Care sector beating the market?
FMCG - Personal Care has underperformed NIFTY 500 by 17.5% over the last 52 weeks and 6.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 3 of 12 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which FMCG - Personal Care stock has the strongest price momentum?
Bajaj Consumer Care Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which FMCG - Personal Care company scores highest for research priority?
Bajaj Consumer Care Ltd scores 73.5 out of 100 with 100% evidence confidence, from 32.3 points on growth and earnings, 16.9 on capital efficiency, 10.3 on valuation and 14 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many FMCG - Personal Care companies does this comparison cover, and over what period?
It compares 12 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the FMCG - Personal Care sector?
The 12 FMCG - Personal Care companies on this page carry ₹8,57,418 crore of combined market value. Hindustan Unilever Ltd is the largest at ₹4,52,766 crore, about 53% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-09-17.
What is the FMCG - Personal Care sector's P/E ratio?
The median price-to-earnings ratio across the 12 FMCG - Personal Care companies on this page is 35.7×, measured on the 12 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-09-17.
How is the FMCG - Personal Care sector performing?
3 of the 12 covered FMCG - Personal Care companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 17.5% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-09-17.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.
Not SEBI Registered !! Not Investment advice !!